We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
-23.9%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
-$151M
(-33%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
49.77%
Holding
317
New
38
Increased
51
Reduced
65
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$3.72M |
| 2 |
Shopify
SHOP
|
+$3.18M |
| 3 |
Autodesk
ADSK
|
+$3.15M |
| 4 |
Salesforce
CRM
|
+$2.94M |
| 5 |
HTZWW
Hertz Global Holdings Warrants
HTZWW
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$9.48M |
| 2 |
argenx
ARGX
|
+$4.12M |
| 3 |
Sea Limited
SE
|
+$3.9M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$3.16M |
| 5 |
Chord Energy
CHRD
|
+$3.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.72% |
| 2 | Healthcare | 26.86% |
| 3 | Communication Services | 13.94% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Financials | 2.18% |
Similar funds
FCM
DA
YLHM
HC
LIM
NQWM
MAM
SWM
Privium Fund Management's Q2 2022 Portfolio in Review
As of Q2 2022, Privium Fund Management held 317 positions worth $302M, down 33% from $452M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Privium Fund Management withdrew a net $22.1M in Q2 2022, closing 65 positions and reducing 65 holdings. Its most notable exit was Royalty Pharma, an estimated $9.48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Privium Fund Management opened a new position in Microsoft worth $2.06M.
- Privium Fund Management's largest Q2 2022 buy was Microsoft: 8,000 shares worth $2.06M.
- Privium Fund Management added most to Snowflake in Q2 2022, an estimated $3.72M increase.
- Privium Fund Management's biggest Q2 2022 reduction was argenx, cutting an estimated $4.12M.
- Privium Fund Management fully exited Royalty Pharma in Q2 2022, selling an estimated $9.48M.
- Privium Fund Management's ten largest holdings make up 50% of its $302M portfolio in Q2 2022.
- Privium Fund Management opened 38 new positions and closed 65 in Q2 2022.
- Privium Fund Management's portfolio value fell 33% quarter-over-quarter to $302M.
Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.